Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Amgen
|
| gptkbp:acquisitionYear |
2002
|
| gptkbp:focus |
immunology
oncology inflammation |
| gptkbp:founded |
1981
|
| gptkbp:foundedIn |
gptkb:Seattle,_Washington,_United_States
|
| gptkbp:founder |
gptkb:Stephen_Duzan
gptkb:Steven_Gillis Christopher Henney |
| gptkbp:headquartersLocation |
gptkb:Seattle,_Washington,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Immunex Corporation
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableEmployee |
Peggy Phillips
Edward Fritzky |
| gptkbp:notableProduct |
gptkb:Enbrel
|
| gptkbp:numberOfEmployees |
~1500 (at time of acquisition)
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
gptkb:IMNX
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:bfsParent |
gptkb:IMNX
|
| gptkbp:bfsLayer |
8
|